Capital World Investors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-968,232
Closed -$98.3M 635
2025
Q4
$98.3M Sell
968,232
-15,172,629
-94% -$1.22B 0.01% 351
2025
Q3
$883M Sell
16,140,861
-2,059,161
-11% -$103M 0.12% 153
2025
Q2
$967M Buy
18,200,022
+364,745
+2% +$18.5M 0.14% 141
2025
Q1
$772M Buy
17,835,277
+297,660
+2% +$15.1M 0.13% 153
2024
Q4
$985M Buy
17,537,617
+1,696,321
+11% +$106M 0.15% 140
2024
Q3
$1.08B Sell
15,841,296
-660,050
-4% -$37.3M 0.17% 136
2024
Q2
$697M Buy
16,501,346
+3,476,033
+27% +$191M 0.11% 156
2024
Q1
$900M Buy
13,025,313
+5,557,168
+74% +$352M 0.15% 144
2023
Q4
$552M Buy
7,468,145
+539,498
+8% +$35.4M 0.1% 182
2023
Q3
$473M Buy
6,928,647
+130,687
+2% +$11.1M 0.09% 187
2023
Q2
$638M Buy
6,797,960
+173,174
+3% +$13.5M 0.12% 168
2023
Q1
$449M Buy
6,624,786
+1,433,399
+28% +$92.1M 0.09% 196
2022
Q4
$257M Buy
5,191,387
+197,698
+4% +$8.08M 0.05% 255
2022
Q3
$162M Sell
4,993,689
-898,689
-15% -$37.1M 0.04% 293
2022
Q2
$232M Buy
5,892,378
+405,369
+7% +$21.7M 0.05% 257
2022
Q1
$384M Buy
5,487,009
+804,159
+17% +$58.8M 0.07% 235
2021
Q4
$364M Sell
4,682,850
-1,286,462
-22% -$114M 0.06% 248
2021
Q3
$570M Buy
5,969,312
+383,649
+7% +$40.5M 0.1% 200
2021
Q2
$694M Sell
5,585,663
-2,822,123
-34% -$337M 0.12% 178
2021
Q1
$1.11B Sell
8,407,786
-1,890,610
-18% -$259M 0.2% 122
2020
Q4
$1.36B Buy
10,298,396
+2,967,886
+40% +$359M 0.26% 94
2020
Q3
$747M Buy
7,330,510
+6,440,510
+724% +$556M 0.16% 132
2020
Q2
$77.4M Hold
890,000
0.02% 332
2020
Q1
$51.6M Hold
890,000
0.02% 329
2019
Q4
$82.3M Hold
890,000
0.02% 319
2019
Q3
$80.4M Hold
890,000
0.02% 304
2019
Q2
$105M Hold
890,000
0.02% 295
2019
Q1
$77.1M Hold
890,000
0.02% 313
2018
Q4
$56.2M Hold
890,000
0.02% 332
2018
Q3
$70.2M Hold
890,000
0.02% 348
2018
Q2
$53.2M Hold
890,000
0.01% 360
2018
Q1
$35.9M Sell
890,000
-860,000
-49% -$42M 0.01% 379
2017
Q4
$91.9M Hold
1,750,000
0.02% 298
2017
Q3
$82.5M Hold
1,750,000
0.02% 316
2017
Q2
$61.9M Hold
1,750,000
0.01% 332
2017
Q1
$41.3M Hold
1,750,000
0.01% 365
2016
Q4
$23.4M Hold
1,750,000
0.01% 387
2016
Q3
$32.5M Hold
1,750,000
0.01% 371
2016
Q2
$21.4M Hold
1,750,000
0.01% 394
2016
Q1
$11.8M Buy
1,750,000
+800,000
+84% +$5.12M ﹤0.01% 437
2015
Q4
$8.77M Buy
+950,000
New +$8.83M ﹤0.01% 480
2014
Q3
Sell
-1,290,000
Closed -$22M 522
2014
Q2
$22M Buy
1,290,000
+780,000
+153% +$10.7M 0.01% 421
2014
Q1
$7.23M Hold
510,000
﹤0.01% 484
2013
Q4
$5.96M Buy
+510,000
New +$5.85M ﹤0.01% 470

Other funds holding EXAS

Capital World Investors's EXAS Position: Q1 2026 in Review

Capital World Investors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 968,232 shares — an estimated $98.3M sold.

Capital World Investors first reported a position in EXAS in Q4 2013 and held it in 44 quarters. The position peaked at $1.36B in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Capital World Investors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Capital World Investors sold 968,232 Exact Sciences shares in Q1 2026, an estimated $98.3M.
  • Capital World Investors first reported a position in Exact Sciences in Q4 2013 and held it in 44 quarters.
  • Capital World Investors's Exact Sciences position peaked at $1.36B in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.